| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/04/2012 | CN101735168B P-sulfamyl benzylidene cyclic ketone compounds, preparation method and application thereof |
| 01/04/2012 | CN101735100B Taspine biphenyl derivative and preparation method thereof |
| 01/04/2012 | CN101717775B Single-chain antibody gene of anti-human death receptor 5 |
| 01/04/2012 | CN101664403B Medicinal composition for treating cancer and signal transduction path thereof |
| 01/04/2012 | CN101658563B Extraction method of raspberry for preventing primary carcinoma of liver |
| 01/04/2012 | CN101632662B Sirolimus preparation and preparation process thereof |
| 01/04/2012 | CN101588800B A method of administering an antitumor compound |
| 01/04/2012 | CN101554472B Novel medical compound being capable of synergetically suppressing growth of tumors |
| 01/04/2012 | CN101549111B Effective component of cogongrass rhizome and preparation method thereof |
| 01/04/2012 | CN101543632B Anti-tumor prodrug having accurate structure and taking novel amphipathic polymer as carrier and synthetic method thereof |
| 01/04/2012 | CN101541323B Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels |
| 01/04/2012 | CN101475632B Recombinant Ganoderma lucidum immunoregulation protein with antineoplastic function and medicinal preparation thereof |
| 01/04/2012 | CN101445544B Method for preparing ginsenoside Rb<1> |
| 01/04/2012 | CN101433563B Effective component of chebula fruit as well as preparation method and use thereof |
| 01/04/2012 | CN101433515B High-efficient low-toxicity ultrasonic microvesicle for carrying ricin A chain and preparation method thereof |
| 01/04/2012 | CN101428064B Effective component of schisandra chinensis, preparation method and use thereof |
| 01/04/2012 | CN101385696B Sodium alginate microspheres blood vessel suppository containing etoposide and preparation method and uses thereof |
| 01/04/2012 | CN101372475B Aromatic heterocyclic substituted acardite derivative and use thereof |
| 01/04/2012 | CN101347567B Effective component of airpotato yam as well as preparation method and use thereof |
| 01/04/2012 | CN101317883B Prunella spike active site and application of the same in preparing medicament composition |
| 01/04/2012 | CN101289444B Pyrimidine derivate and medicinal use thereof |
| 01/04/2012 | CN101255121B Preparation technique of lysine rhein and use thereof in tumour therapy |
| 01/04/2012 | CN101248078B Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 01/04/2012 | CN101244055B Application of oroxylin in pharmacy |
| 01/04/2012 | CN101239964B 15-oxospiramilactone and its medicament composition, preparation method and application |
| 01/04/2012 | CN101239936B Antineoplastic sulfur-containing alkannin and naphthoquinones derivatives |
| 01/04/2012 | CN101209264B Total toadpoison lactones extraction with anti-tumor function, preparation and application thereof |
| 01/04/2012 | CN101181440B Chinese medicine composition for curing hemopathy as well as preparation method and usage thereof |
| 01/03/2012 | US8088906 FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof |
| 01/03/2012 | US8088887 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 01/03/2012 | US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/03/2012 | US8088802 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 01/03/2012 | US8088795 Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53 |
| 01/03/2012 | US8088774 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 01/03/2012 | US8088762 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/03/2012 | US8088760 Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP) |
| 01/03/2012 | US8088605 Exopolysaccharides delivery system for active molecules |
| 01/03/2012 | US8088388 Complexing; water in oil emulsion; immunostimulant |
| 01/03/2012 | US8088383 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
| 01/03/2012 | US8088377 Human monoclonal antibodies against CD30 |
| 01/03/2012 | CA2643972C Hepoxilin analog enantiomers |
| 01/03/2012 | CA2636077C Thiazole compounds as protein kinase b (pkb) inhibitors |
| 01/03/2012 | CA2632556C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 01/03/2012 | CA2632194C N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 01/03/2012 | CA2544720C The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person |
| 01/03/2012 | CA2524525C Novel pyridopyrazines and use thereof as kinase modulators |
| 01/03/2012 | CA2515132C Heteroaryl substituted pyrroles useful as inhibitors of protein kinases |
| 01/03/2012 | CA2514873C Compositions and methods for inhibiting tumor growth and metastasis |
| 01/03/2012 | CA2514407C Thienopyrimidine compounds and use thereof |
| 01/03/2012 | CA2508932C Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
| 01/03/2012 | CA2501610C Epothilone derivatives for the treatment of multiple myeloma |
| 01/03/2012 | CA2501087C Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer |
| 01/03/2012 | CA2496902C Medicament for activating the phagocytic capacity of macrophages |
| 01/03/2012 | CA2495060C Derivatives of pyrrolo-pyrazines having a kinase inhibitory activity and their biological applications |
| 01/03/2012 | CA2491612C 4-'7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents |
| 01/03/2012 | CA2491216C Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 01/03/2012 | CA2488565C Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 01/03/2012 | CA2480423C Truncated 24 kda basic fibroblast growth factor |
| 01/03/2012 | CA2480356C Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/03/2012 | CA2475604C An herpes simplex virus complex |
| 01/03/2012 | CA2466054C Apo-2 ligand/trail formulations |
| 01/03/2012 | CA2465117C Lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 01/03/2012 | CA2464309C Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 01/03/2012 | CA2463974C Dendrimers for use in targeted delivery |
| 01/03/2012 | CA2457719C Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 01/03/2012 | CA2456717C Phenyl derivatives as factor xa inhibitors |
| 01/03/2012 | CA2455972C N6-benzyl and phenyl substituted adenines and their use as cosmetics, pharmaceutical preparations and plant growth regulators |
| 01/03/2012 | CA2452151C Use of cyclopamine, an inducer of the differentiation and apoptosis of the basal cell carcinoma (bcc) cells, in the treatment of bcc's and other tumors that use the hedgehog/smoothened pathway for proliferation of apoptosis |
| 01/03/2012 | CA2436049C A serpin in bifidobacteria |
| 01/03/2012 | CA2423220C Modified prodrug forms of ap/amp |
| 01/03/2012 | CA2420618C Percarboxylated polysaccharides, and a process for their preparation |
| 01/03/2012 | CA2399293C Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 01/03/2012 | CA2378574C Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody |
| 01/03/2012 | CA2348698C Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 01/03/2012 | CA2347025C Zinc finger binding domains for gnn |
| 01/03/2012 | CA2334960C Combination of tgf-.beta. inhibition and immune stimulation to treat hyperproliferative diseases |
| 01/03/2012 | CA2264562C Sustained peptide-release formulation |
| 01/03/2012 | CA2227265C Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis |
| 01/03/2012 | CA2226973C Modulators of the function of fas receptors and other proteins |
| 01/03/2012 | CA2224468C P53 protein variants and therapeutical uses thereof |
| 01/03/2012 | CA2210998C Inhibition of neovascularization using vegf-specific oligonucleotides |
| 01/03/2012 | CA2209771C Combined therapeutical treatment of hyperproliferative diseases |
| 12/29/2011 | WO2011163554A2 Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis |
| 12/29/2011 | WO2011163533A2 One step removal of selected molecules from body fluid and tissue |
| 12/29/2011 | WO2011163527A1 Pyrrolo- pyrazine derivatives useful as inhibitors of atr kinase |
| 12/29/2011 | WO2011163483A2 Polymers for biomaterials and therapeutics |
| 12/29/2011 | WO2011163478A2 Dual variable domain immunoglobulins and uses thereof |
| 12/29/2011 | WO2011163466A1 Regulation of skin pigmentation by neuregulin-1 (nrg-1) |
| 12/29/2011 | WO2011163430A1 Polymorphs of osi-906 |
| 12/29/2011 | WO2011163312A2 Improving efficacy of cancer therapy |
| 12/29/2011 | WO2011163308A2 Compositions and methods for preventing and treating organ injury and/or dysfunction |
| 12/29/2011 | WO2011163222A1 Nilotinib salts and crystalline forms thereof |
| 12/29/2011 | WO2011163198A2 Tg2 inhibitors and uses thereof |
| 12/29/2011 | WO2011163195A1 Fused pyrrole derivatives as pi3k inhibitors |
| 12/29/2011 | WO2011162835A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors |
| 12/29/2011 | WO2011162558A2 Recombinant vector for suppressing proliferation of human papillomavirus cell including adenylate cyclase activating polypeptide 1 (pituitary) gene and pharmaceutical composition for treating human papillomavirus |
| 12/29/2011 | WO2011162515A2 Novel fused pyrimidine derivatives for inhd3ition of tyrosine kinase activity |
| 12/29/2011 | WO2011162419A1 Tumor growth controlling method targeting galactosylceramide expression factor-1 |
| 12/29/2011 | WO2011162416A1 Agent for suppressing the formation of abnormal skin cells caused by exposure to light |
| 12/29/2011 | WO2011162413A1 Sustained-release formulation |